Programs > Full Time programs > d·HEALTH Barcelona > The Faculty

— d·HEALTH Barcelona

What is d·HEALTH Barcelona

The Program

Impact & Outcomes

Our Start-ups

The Faculty


Who is this program for?

Career Opportunities

The Fellows


Application Process

Become a Partner


DURATION: 9 month Full Time Program

Thu, 17 January 2019

PROFILES: Graduates and PhDs in Health and Life Sciences Engineering, Business and Design.

LOCATIONS: Hospital Clínic - Germans Tries i Pujol Hospital - Vall d’Hebron Barcelona Hospital Campus - Barcelona Science Park

LANGUAGES: English/Spanish


The Faculty

Lecturers | Network | Staff | Mentors


Co-Founder and Chief Executive Officer (CEO), Spherium (Barcelona)

Luis Ruiz Ávila is one of the founding partners and current CEO of Spherium, a firm that provides operational, strategic and business development expertise to transform into economic value academic knowledge or related projects from established companies in the biomedical sector. His responsibility is the acquisition of projects and further business development. Luis started his career in the industry at Almirall in 1997 as project manager and business developer. In 2001 he left Almirall to participate in creating Advancell, one of the first Spanish biotechnology spin-offs, where he served as CEO from its conception until December 2008, when he left his position to create Janus. In 2002 he participated in the creation of ERA-Plantech (now ERA-Biotech), being interim CEO until 2004, when he became Chairman of its Board of Directors until 2007. In 2009 he served as CEO of the Madrid based company TCD-Pharma, Biotech Crossroads Group. He was a member of the board of Asebio between 2004 and 2008. He is the founder of CataloniaBio, the Catalan association of biotech companies, and member of its board. Luis regularly participates in working groups of local institutions, particularly Biocat. Luis holds a PhD in Molecular Genetics from the Spanish Research Council (CSIC), and, before joining industry, he spent the first 10 years of his career as a researcher and lecturer in different academic positions in various Universities and Research Centers in Spain and in the US (Roche, Mount Sinai NY). He has authored over 25 research papers in prestigious international journals (Nature, PNAS, J. Neurosci) and translated into Spanish several reference textbooks in molecular biology and genetics. He regularly contributes opinion articles on biotechnology management in newspapers and magazines at national level. Occasionally teaches courses in project management and intellectual property, and is an active lecturer in communication and management strategy in the biotechnology and biomedical field.